Groupe Bruxelles Lambert SA Vs. NovoCure Industry Stock Comparison

Buy

55

GBLBY
Groupe Bruxelles Lambert SA

Last Price:

7.24

Seasonality Move:

-1.98%

Buy

75

NVCR
NovoCure

Last Price:

33.40

Seasonality Move:

-5.24%

Buy

55

Groupe Bruxelles Lambert SA (GBLBY) is a Buy

Is Groupe Bruxelles Lambert SA a Buy, Sell or Hold?

The current Groupe Bruxelles Lambert SA [GBLBY] share price is $7.24. The Score for GBLBY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
GBLBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

75

NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GBLBY Stock Price Chart

What is Groupe Bruxelles Lambert SA's stock price today?

The Groupe Bruxelles Lambert SA share price today is $7.24
The current trend is relatively stagnant and GBLBY is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $33.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GBLBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.07	Sell
Relative Strength Index (14 RSI):	50.17	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(6.93 - 7.41)	Buy
Bollinger Bands (100):	(7.19 - 7.99)	Sell

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.78	Buy
Relative Strength Index (14 RSI):	75.34	Buy
Chaikin Money Flow:	1118573	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(16.36 - 28.56)	Buy
Bollinger Bands (100):	(14.7 - 22.78)	Buy

GBLBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	7.16	Buy
20-day SMA:	7.16	Buy
50-day SMA:	7.45	Sell
200-day SMA:	7.74	Sell
8-day EMA:	7.16	Buy
20-day EMA:	7.18	Buy
50-day EMA:	7.37	Sell
200-day EMA:	7.69	Sell

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	29.6	Buy
20-day SMA:	23.68	Buy
50-day SMA:	19.33	Buy
200-day SMA:	17.9	Buy
8-day EMA:	29.53	Buy
20-day EMA:	25.45	Buy
50-day EMA:	21.38	Buy
200-day EMA:	19.88	Buy

Groupe Bruxelles Lambert SA Earnings Growth & GBLBY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Groupe Bruxelles Lambert SA Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):